MIMEDX GROUP, - COURT CONCLUDES FDA CLASSIFICATION OF AXIOFILL AS BIOLOGICAL PRODUCT WAS "ARBITRARY AND CAPRICIOUS"

Reuters · 2d ago

Please log in to view news